A Phase 2b, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study of Batoclimab Treatment in Adult Participants With Active Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Protocol No
NEURO-IMVT-1401-2401-CIDP
Staff Member
Michael P Collins
Phase
II
Summary

This project is being done to find out if a study drug called batoclimab is safe and helps people with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
Objective
Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
Neuromuscular Disorders, Brain, Spinal Cord, and Nervous System
ClinicalTrials.gov
https://www.clinicaltrials.gov/study/NCT05581199